-
Chiesi Global Rare Diseases Announces Publication of Results from Fabry Disease Patient Survey
24 Apr 2024 18:40 GMT
… and monitoring of patients with Fabry disease for healthcare providers, researchers, … regimen.
"Treatments for Fabry disease have improved the management and … announces-publication-of-results-from-fabry-disease-patient-survey-302125144.html
SOURCE …
-
Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024
24 Apr 2024 20:47 GMT
… -920 (isaralgagene civaparvovec) for treating Fabry disease following the presentation of data …
-
Chiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents
24 Apr 2024 16:22 GMT
… found widespread unmet needs among Fabry disease patients taking drugs such as … won FDA approval for the Fabry disease drug Elfabrio last year. Patients …
-
Plant-Based Biologics Market Forecast 2031: $182.9 Million Valuation Predicted by Allied Market Research
24 Apr 2024 08:08 GMT
…
Based on target disease, the Fabry disease segment accounted for the highest …
-
One Big Step Away From BLA Submission for Sangamo’s Fabry Gene Therapy
23 Apr 2024 11:53 GMT
… -920 (isaralgagene civaparvovec) for treating Fabry disease following the presentation of data … treatment option for adults with Fabry disease.”
Hopkin presented updated data from … Eligibility for ST-920 in Fabry Disease. News release. Sangamo Therapeutics. …
-
Improving Quality of Life in Patients With Fabry With Gene Therapy
23 Apr 2024 01:17 GMT
… (isaralgagene civaparvovec) for treating Fabry disease.1 The FDA advised, … used in studies of Fabry disease, and then a gastrointestinal … trial, this treatment of Fabry disease has an excellent safety … variety of presentations with Fabry disease, and we hope to …
-
Chiesi Group's 2023 Revenue Surpasses €3 Billion
22 Apr 2024 17:32 GMT
… treatment of adults with confirmed Fabry disease was approved in Europe, the …
-
Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices
22 Apr 2024 13:49 GMT
… treatment of adults with confirmed Fabry disease was approved in Europe, the …
-
Chiesi Group celebrates €3bn sales success in 2023
22 Apr 2024 13:05 GMT
… treatments targeting Alpha-Mannosidosis and Fabry disease underscored Chiesi’s commitment to …
-
Death notices and funeral announcements in The Chronicle Newcastle from April 12 to April 18
21 Apr 2024 04:26 GMT
… donations too, to the National Fabry Disease Foundation. All enquiries to Regent …